Sign in

CIK 0001829802

  • Emerging growth company

Faeth Therapeutics, Inc.

Sign in to watch
Ticker
FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 512-200-2982
Business address
701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
Former names
Sensei Biotherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 12 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-01 Cambrian BioPharma Inc 10% owner Purchase +2,458 $3.60 $9K 5,230,786
2022-02-28 Peyer James Director Purchase +42 $3.60 $151 5,228,328
2022-02-28 Cambrian BioPharma Inc 10% owner Purchase +42 $3.60 $151 5,228,328
2022-02-25 Peyer James Director Purchase +2,500 $3.65 $9K 5,228,286
2022-02-25 Cambrian BioPharma Inc 10% owner Purchase +2,500 $3.65 $9K 5,228,286
2022-02-24 Cambrian BioPharma Inc 10% owner Purchase +15,000 $3.63 $54K 5,225,786
2022-02-24 Peyer James Director Purchase +15,000 $3.63 $54K 5,225,786
2022-02-23 Cambrian BioPharma Inc 10% owner Purchase +2,500 $3.80 $10K 5,210,786
2022-02-23 Peyer James Director Purchase +2,500 $3.80 $10K 5,210,786
2022-02-18 Peyer James Director Purchase +15,000 $3.97 $60K 5,208,286
2022-02-18 Cambrian BioPharma Inc 10% owner Purchase +15,000 $3.97 $60K 5,208,286
2022-02-17 Peyer James Director Purchase +4,949 $4.17 $21K 5,193,286
2022-02-17 Cambrian BioPharma Inc 10% owner Purchase +4,949 $4.17 $21K 5,193,286
2022-02-16 Cambrian BioPharma Inc 10% owner Purchase +2,551 $4.25 $11K 5,188,337
2022-02-16 Peyer James Director Purchase +2,551 $4.25 $11K 5,188,337
2022-02-15 Pierce Robert Hamilton Chief R&D Officer Grant or award +21,000 21,000
2022-02-15 Pierce Robert Hamilton Chief R&D Officer Grant or award · Stock Option (Right to Buy) +62,000 62,000
2022-02-15 Colgan Erin Chief Financial Officer Grant or award +21,000 21,686
2022-02-15 Colgan Erin Chief Financial Officer Grant or award · Stock Option (Right to Buy) +62,000 62,000
2022-02-15 Celebi John President and CEO Grant or award +53,900 54,114

Page 13 of 20 · 385 trades